Cargando…
Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data
OBJECTIVES: Establishing a correlate of protection is essential for the development and licensure of Shigella vaccines. We examined potential threshold levels of serum IgG to Shigella lipopolysaccharide (LPS) that could predict protection against shigellosis. METHODS: We performed new analyses of se...
Autores principales: | Cohen, Dani, Ashkenazi, Shai, Schneerson, Rachel, Farzam, Nahid, Bialik, Anya, Meron-Sudai, Shiri, Asato, Valeria, Goren, Sophy, Baran, Tomer Ziv, Muhsen, Khitam, Gilbert, Peter B., MacLennan, Calman A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993342/ https://www.ncbi.nlm.nih.gov/pubmed/36243351 http://dx.doi.org/10.1016/j.cmi.2022.10.011 |
Ejemplares similares
-
Detoxified O-Specific Polysaccharide (O-SP)–Protein Conjugates: Emerging Approach in the Shigella Vaccine Development Scene
por: Cohen, Dani, et al.
Publicado: (2022) -
Pentraxin 3 and Shigella LPS and IpaB Antibodies Interplay to Defeat Shigellosis
por: Meron-Sudai, Shiri, et al.
Publicado: (2022) -
A Shigella flexneri 2a synthetic glycan-based vaccine induces a long-lasting immune response in adults
por: Meron-Sudai, Shiri, et al.
Publicado: (2023) -
Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study
por: Chisenga, Caroline C., et al.
Publicado: (2021) -
Frontiers in Shigella Vaccine Development
por: MacLennan, Calman Alexander, et al.
Publicado: (2022)